- Hospital
- Medical Center
- Research Institute
- Blood Products
- Non Plasma Derived Coagulation Factor
- CSL Behring
- Bayer
-
North America
- U.S.A
- Canada
- Europe
- France
- Germany
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Latin America
- Brazil
- Middle East and Africa
- Market Forecast for 2024-2030
- Market growth drivers
- Challenges and Opportunities
- Emerging and Current market trends
- Market player Capacity, Production, Revenue (Value)
- Supply (Production), Consumption, Export, Import analysis
- End user/application Analysis
Blood Coagulation Factor Market Analysis & Forecast 2024-2030
Blood Coagulation Factor Market by Product Type (Blood Products, Non Plasma Derived Coagulation Factor ) by Application / End User (Hospital, Medical Center, Research Institute ) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)
Global Blood Coagulation Factor Market is expected to reach USD 10222.18 million by 2031 with CAGR of 7.7 % between 2025 and 2031
Profshare Market Research publishes Global Blood Coagulation Factor Market Report 2024 to 2030 to provide in-depth market information. The study covers a detailed analysis, growth and forecast of the Blood Coagulation Factor Market. The report includes market analysis on global and regional level. The study covers historical data analysis from 2018 to 2023 and market forecast for 2024 to 2030 based on revenue generated. The study includes market value in terms of revenue in billion USD for years 2018-2030 and compound annual growth rate (CAGR) in % from 2024 to 2030.
Blood Coagulation, is the process which includes forming of blood clot. The blood clot formation is often referred to as secondary hemostasis, because it forms the second stage in the process of arresting the loss of blood from a ruptured vessel. The first stage called primary hemostasis, is characterized by blood vessel constriction (vasoconstriction) and platelet aggregation at the site of vessel injury. Under abnormal circumstances, occlusion (blockage) of the vessel occurs due to formation of clot in vessel that has not been broken or breached.
Coagulation or Clotting process involves sequential interaction of numerous blood components called coagulation factors. Coagulation process includes 13 principal coagulation factors in all, and each of these has been assigned a Roman numeral, I to XIII. Coagulation process initiates with activation of two separate pathways, designated extrinsic and intrinsic. Both pathways result in the production of factor X. The activation of this factor initiates so-called common pathway of coagulation, that leads to formation of a clot.
Blood Coagulation process involves following Factors
Blood Coagulation Factor Market: Application / End User
Blood Coagulation Factor Market: Product Type
Global Blood Coagulation Factor Market: Competitive Analysis
Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study consists of following key players in Blood Coagulation Factor Market:
The report provides Blood Coagulation Factor Market Dynamics, includes industry growth drivers, challenges, opportunities,risk, constraints as well as threats. Report also includes Manufacturing Cost Analysis mainly included Raw Materials Analysis, Price Trend of product, Mergers & Acquisitions, Expansion, Key Suppliers of product, Concentration Rate of Market, Manufacturing Process Analysis. Research Report contains Market Effect Factors analysis mainly included Technology Progress, Consumer Needs Trend, External Environmental Change.
Global Blood Coagulation Factor Market: Regional Analysis
Global Blood Coagulation Factor Market Report delivers a comprehensive analysis of the following parameters:
Report Coverage
| Parameters | Details |
|---|---|
Base Year |
2024 |
Historical Data |
2018-2023 |
Forecast Data |
2024-2030 |
Base Year Value (2024) |
USD 6081.82 million |
Forecast Value (2031) |
USD 10222.18 million |
CAGR (2025-2030) |
7.7 % |
Regional Scope |
North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW |
Frequently Asked Questions (FAQ)
Blood Coagulation Factor Market was valued at around USD 6081.82 million in 2023 & estimated to reach USD 10222.18 million by 2030.
Blood Coagulation Factor Market is likely to grow at Compound Annual Growth Rate (CAGR) of 7.7% between 2024 to 2030.
Blood Coagulation Factor Market is dominated by the Blood Products segment and the North America region holds the highest market share in 2023.
Some of the top key players in the Blood Coagulation Factor Market are CSL Behring, Bayer.
Primary driving factors for the growth of the Blood Coagulation Factor Market include Increasing approval rate of Novel drugs around the globe..
Yes, the report includes COVID 19 impact on the market.
We are committed to offering 100 % free customization while purchasing.